KESTRA MEDICAL TECHNOLOGIES, LTD.

Kestra Medical Technologies operates as a wearable medical device and digital healthcare company focused on cardiovascular disease management. The company develops and commercializes the Cardiac Recovery System platform, which integrates patient monitoring, therapeutic treatment, digital health tools, and support services. The platform's primary product is the ASSURE wearable cardioverter defibrillator (WCD), a wearable device designed to protect patients at elevated risk of sudden cardiac arrest. The company complements its hardware offering with a suite of integrated digital solutions and services intended to enhance engagement between patients and healthcare providers.

Kestra was founded in 2014 and is headquartered in Kirkland, Washington. The company operates with approximately 330 full-time employees and is incorporated in Bermuda with its shares listed on the Nasdaq. The company primarily serves the U.S. cardiovascular medical device market, addressing the need for temporary cardiac protection in patients with reduced ejection fraction, acute myocardial infarction, and other high-risk conditions. Revenue is generated through device sales and related digital health services and patient support offerings associated with the Cardiac Recovery System platform.